Q&A: Portland’s Gray Optics sees demand for precision components in COVID-19 tests

Founded in 2017, Gray Optics develops advanced imaging technologies and optical systems for biomedical, life sciences and industrial applications.

This year, the Portland company saw a surge in demand from manufacturers of COVID-19 “point-of-care” tests, which provide disease detection and diagnosis within minutes. Test manufacturers have come to Gray Optics asking for customized optical systems that are an integral part of the tests.

The challenge? Many rapid tests rely on fluorescence detection using a lens that must be precisely aligned, with regard to specifications such as field-of-view and depth-of-field, to a digital image sensor. The Gray Optics team designed those precision optical components for manufacturing at scale. Read more

Related Posts

Maine’s life sciences sector growth could outpace other industries

Maine’s $2.3 billion life sciences sector, which employed close to 10,000 people in 2024, will outpace the growth of many other...

13 January 2025

IDEXX gets wiggle room to buy back more shares

IDEXX Laboratories Inc. (Nasdaq: IDXX), a Westbrook-based maker of veterinary diagnostics and software, has the green light from its board of...

10 December 2024

Maine’s first accredited lab for PFAS testing is expanding to meet demand

NORRIDGEWOCK, Maine — This week, the Biden administration moved to prevent dangerous “forever chemicals” from being released onto the market after a less...

6 December 2024